- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
GE introduces mobile PET camera
Riding the wave of increased interest in dedicated PET systems, GE Medical Systems presented a mobile version of its Advance dedicated PET unit at the RSNA show. Mobile PET Advance was featured on panels in GE’s booth, and a unit was displayed in
Riding the wave of increased interest in dedicated PET systems, GE Medical Systems presented a mobile version of its Advance dedicated PET unit at the RSNA show. Mobile PET Advance was featured on panels in GEs booth, and a unit was displayed in the booth of the Waukesha, WI-based firms mobile partner, Calumet Coach. GE plans to certify two other mobile providers in the next few months, and expects to begin shipping the unit in the 0second quarter.
The company has placed more than 100 Advance PET systems worldwide since the units launch. GE is now shipping one Advance per week, and expects sales to double in the coming year, according to Beth Klein, general manager of GEs global nuclear/PET business.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
Shaping the Future of Radiology in 2025: Trends, Threats, and Opportunities
January 10th 2025How do we respond to challenges with staff recruitment, cybersecurity, and looming hospital takeovers in radiology? This author assesses key trends in radiology and offers key insights to stay competitive in the field.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
